Sofocure 400mg Tablet from Emcure Pharmaceuticals contains Sofosbuvir 400 mg for the treatment of chronic hepatitis C virus infection. As a nucleotide analogue, it blocks NS5B polymerase, the enzyme responsible for copying the viral genome, halting replication and allowing the body to clear the virus from the blood over the treatment period. Sofosbuvir is prescribed together with another direct-acting antiviral – and sometimes ribavirin – in a combination chosen by your doctor according to genotype and liver condition. Pack of 28 tablets.

Key Features

• Sofosbuvir 400 mg – NS5B polymerase inhibitor
• Core component of combination hepatitis C therapy
• Taken with another antiviral, not on its own
• One tablet daily, with or without food
• Pack of 28 tablets from Emcure Pharmaceuticals Ltd.

Composition

• Sofosbuvir – 400 mg per tablet (NS5B polymerase inhibitor)

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection, in combination with other antivirals
• Steadily lowers the amount of virus in the blood over the course of treatment
• High cure rates when the full prescribed course is completed
• Can be used in compensated cirrhosis under specialist supervision
• Clearing the virus reduces the long-term risk of liver failure and liver cancer
• Simple one-tablet-a-day dosing alongside the partner medicine

Directions for Use

• Take exactly as prescribed – usually one tablet once daily with the partner antiviral
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but keep to the same time each day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Never take sofosbuvir alone. Monotherapy does not cure hepatitis C and encourages resistance
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort and certain HIV medicines, which can make treatment fail
• Common side effects include headache, tiredness, nausea and insomnia; anaemia is more likely if ribavirin is added
• Avoid alcohol; use with caution in severe kidney disease, and do not drive if you feel dizzy

Storage

• Store below 30°C in a dry place
• Keep in the original pack, protected from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician.

The post Sofocure 400 mg Tablet appeared first on PMC Herbals.

Hepcinat Tablet from Natco Pharma contains Sofosbuvir 400 mg, the nucleotide analogue that transformed hepatitis C from a hard-to-treat chronic infection into a curable one. It works by inhibiting NS5B polymerase, the enzyme the virus depends on to copy its own RNA; once that step is blocked, viral replication stops. Sofosbuvir is not used on its own – it is always combined with another direct-acting antiviral such as daclatasvir, velpatasvir or ledipasvir, and sometimes with ribavirin, depending on genotype and liver status. Strip of 28 tablets, four weeks of therapy.

Key Features

• Sofosbuvir 400 mg – NS5B polymerase inhibitor
• Backbone of nearly every modern hepatitis C regimen
• Always used in combination with another antiviral, never alone
• One tablet daily, with or without food
• Strip of 28 tablets from Natco Pharma Ltd.

Composition

• Sofosbuvir – 400 mg per tablet (NS5B polymerase inhibitor)

Refer to the pack label and package insert for the complete list of excipients.

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection, in combination with other antivirals
• Steadily lowers the amount of virus in the blood over the course of treatment
• High cure rates when the full prescribed course is completed
• Can be used in compensated cirrhosis under specialist supervision
• Clearing the virus reduces the long-term risk of liver failure and liver cancer
• Simple one-tablet-a-day dosing alongside the partner medicine

Directions for Use

• Take exactly as prescribed – usually one tablet once daily with the partner antiviral
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but keep to the same time each day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Never take sofosbuvir alone. Monotherapy does not cure hepatitis C and encourages resistance
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort and certain HIV medicines, which can make treatment fail
• Common side effects include headache, tiredness, nausea and insomnia; anaemia is more likely if ribavirin is added
• Avoid alcohol; use with caution in severe kidney disease, and do not drive if you feel dizzy

Storage

• Store below 30°C in a dry place
• Keep in the original pack, protected from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician.

The post Hepcinat Tablet appeared first on PMC Herbals.

MY Hep 400mg Tablet from Mylan (a Viatris company) contains Sofosbuvir 400 mg, a direct-acting antiviral for chronic hepatitis C. Sofosbuvir is a nucleotide analogue that targets NS5B polymerase – the enzyme the hepatitis C virus uses to replicate its genome – and shuts that process down, so viral levels in the blood fall steadily over the course of treatment. It must be taken alongside another direct-acting antiviral, and sometimes ribavirin, in a regimen your specialist selects based on genotype and the state of your liver. Pack of 28 tablets.

Key Features

• Sofosbuvir 400 mg – NS5B polymerase inhibitor
• Direct-acting antiviral with a well-established safety record
• Prescribed in combination, never as monotherapy
• One tablet daily, with or without food
• Pack of 28 tablets from Mylan Pharmaceuticals

Composition

• Sofosbuvir – 400 mg per tablet (NS5B polymerase inhibitor)

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection, in combination with other antivirals
• Steadily lowers the amount of virus in the blood over the course of treatment
• High cure rates when the full prescribed course is completed
• Can be used in compensated cirrhosis under specialist supervision
• Clearing the virus reduces the long-term risk of liver failure and liver cancer
• Simple one-tablet-a-day dosing alongside the partner medicine

Directions for Use

• Take exactly as prescribed – usually one tablet once daily with the partner antiviral
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but keep to the same time each day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Never take sofosbuvir alone. Monotherapy does not cure hepatitis C and encourages resistance
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort and certain HIV medicines, which can make treatment fail
• Common side effects include headache, tiredness, nausea and insomnia; anaemia is more likely if ribavirin is added
• Avoid alcohol; use with caution in severe kidney disease, and do not drive if you feel dizzy

Storage

• Store below 30°C in a dry place
• Keep in the original pack, protected from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician.

The post MY Hep 400 mg Tablet appeared first on PMC Herbals.

Sofocure-V Tablet from Emcure Pharmaceuticals combines Sofosbuvir 400 mg and Velpatasvir 100 mg for chronic hepatitis C virus infection. The two direct-acting antivirals block different stages of viral replication – sofosbuvir the NS5B polymerase that copies the genome, velpatasvir the NS5A protein required to assemble and release new virus particles. Because they act independently, the virus is far less able to develop resistance, and a 12-week course clears the infection in over 95% of patients. Pack of 28 tablets.

Key Features

• Sofosbuvir 400 mg + Velpatasvir 100 mg fixed-dose combination
• Effective across all six HCV genotypes
• Dual mechanism limits the development of resistance
• One tablet daily – pack of 28 tablets
• From Emcure Pharmaceuticals Ltd.

Composition

• Sofosbuvir – 400 mg (NS5B polymerase inhibitor)
• Velpatasvir – 100 mg (NS5A inhibitor)

Refer to the pack label and package insert for the complete list of excipients.

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and over
• Effective across all six HCV genotypes – no genotype testing needed before starting
• Clears the virus from the blood in over 95% of patients on a completed course
• Can be used in compensated cirrhosis, and with ribavirin in decompensated disease
• Reduces the long-term risk of liver failure and liver cancer once the virus is cleared
• Simple one-tablet-a-day regimen, typically for 12 weeks

Directions for Use

• Take exactly as prescribed – usually one tablet once daily for 12 weeks
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but take it at the same time every day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury – your doctor will screen and monitor for this
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort, certain HIV medicines and antacids, which can make this treatment fail
• Common side effects include headache, tiredness, nausea, diarrhoea, insomnia and anaemia
• Use with caution in severe kidney disease; liver function is monitored throughout treatment
• Avoid alcohol; it may cause dizziness or blurred vision, so do not drive until you know how it affects you

Storage

• Store below 30°C in a dry place
• Keep in the original bottle with the cap tightly closed; protect from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician, with the appropriate baseline tests.

The post Sofocure-V Tablet appeared first on PMC Herbals.

Myhep All Tablet from Mylan (a Viatris company) provides Sofosbuvir 400 mg with Velpatasvir 100 mg in one daily tablet for chronic hepatitis C. The name reflects its reach: unlike earlier genotype-specific regimens, this pairing treats all six HCV genotypes, so patients can start therapy without waiting for genotype results. Sofosbuvir inhibits the NS5B polymerase and velpatasvir the NS5A protein, and the two together clear the virus in the great majority of patients over a 12-week course. Bottle of 28 tablets.

Key Features

• Sofosbuvir 400 mg + Velpatasvir 100 mg fixed-dose combination
• Pangenotypic – one regimen for all six HCV genotypes
• Single daily tablet, with or without food
• Bottle of 28 tablets – four weeks of therapy
• From Mylan Pharmaceuticals, a Viatris company

Composition

• Sofosbuvir – 400 mg (NS5B polymerase inhibitor)
• Velpatasvir – 100 mg (NS5A inhibitor)

Refer to the pack label and package insert for the complete list of excipients.

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and over
• Effective across all six HCV genotypes – no genotype testing needed before starting
• Clears the virus from the blood in over 95% of patients on a completed course
• Can be used in compensated cirrhosis, and with ribavirin in decompensated disease
• Reduces the long-term risk of liver failure and liver cancer once the virus is cleared
• Simple one-tablet-a-day regimen, typically for 12 weeks

Directions for Use

• Take exactly as prescribed – usually one tablet once daily for 12 weeks
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but take it at the same time every day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury – your doctor will screen and monitor for this
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort, certain HIV medicines and antacids, which can make this treatment fail
• Common side effects include headache, tiredness, nausea, diarrhoea, insomnia and anaemia
• Use with caution in severe kidney disease; liver function is monitored throughout treatment
• Avoid alcohol; it may cause dizziness or blurred vision, so do not drive until you know how it affects you

Storage

• Store below 30°C in a dry place
• Keep in the original bottle with the cap tightly closed; protect from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician, with the appropriate baseline tests.

The post Myhep All Tablet appeared first on PMC Herbals.

Sovihep V Tablet from Zydus Cadila combines Sofosbuvir 400 mg with Velpatasvir 100 mg for the treatment of chronic hepatitis C. The two direct-acting antivirals interrupt viral replication at separate points – sofosbuvir at the NS5B polymerase, velpatasvir at the NS5A assembly protein – which both raises the cure rate and reduces the chance of the virus escaping treatment. It is effective against all six HCV genotypes, so therapy can start without prior genotyping. Bottle of 28 tablets, one month of a standard course.

Key Features

• Sofosbuvir 400 mg + Velpatasvir 100 mg fixed-dose combination
• Works against all six HCV genotypes
• Dual mechanism reduces the risk of viral resistance
• One tablet daily – bottle of 28 tablets
• From Zydus Cadila

Composition

• Sofosbuvir – 400 mg (NS5B polymerase inhibitor)
• Velpatasvir – 100 mg (NS5A inhibitor)

Refer to the pack label and package insert for the complete list of excipients.

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and over
• Effective across all six HCV genotypes – no genotype testing needed before starting
• Clears the virus from the blood in over 95% of patients on a completed course
• Can be used in compensated cirrhosis, and with ribavirin in decompensated disease
• Reduces the long-term risk of liver failure and liver cancer once the virus is cleared
• Simple one-tablet-a-day regimen, typically for 12 weeks

Directions for Use

• Take exactly as prescribed – usually one tablet once daily for 12 weeks
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but take it at the same time every day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury – your doctor will screen and monitor for this
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort, certain HIV medicines and antacids, which can make this treatment fail
• Common side effects include headache, tiredness, nausea, diarrhoea, insomnia and anaemia
• Use with caution in severe kidney disease; liver function is monitored throughout treatment
• Avoid alcohol; it may cause dizziness or blurred vision, so do not drive until you know how it affects you

Storage

• Store below 30°C in a dry place
• Keep in the original bottle with the cap tightly closed; protect from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician, with the appropriate baseline tests.

The post Sovihep V Tablet appeared first on PMC Herbals.

Velpaclear Tablet is Abbott India’s Sofosbuvir 400 mg and Velpatasvir 100 mg combination for chronic hepatitis C, manufactured by Hetero Labs at Baddi under licence from Gilead Sciences Ireland. Sofosbuvir shuts down the NS5B polymerase that copies viral RNA, while velpatasvir blocks the NS5A protein needed to assemble new virus. The combination is pangenotypic – it works across all six HCV genotypes – so treatment can begin without genotype testing. Supplied as 1 x 28 tablets, four weeks of a typical 12-week course.

Key Features

• Sofosbuvir 400 mg + Velpatasvir 100 mg fixed-dose combination
• Made under licence from Gilead Sciences Ireland
• Pangenotypic – covers all six HCV genotypes
• One tablet daily, with or without food
• Bottle of 28 tablets, distributed by Abbott India Limited

Composition

• Sofosbuvir – 400 mg (NS5B polymerase inhibitor)
• Velpatasvir – 100 mg (NS5A inhibitor)

Refer to the pack label and package insert for the complete list of excipients.

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and over
• Effective across all six HCV genotypes – no genotype testing needed before starting
• Clears the virus from the blood in over 95% of patients on a completed course
• Can be used in compensated cirrhosis, and with ribavirin in decompensated disease
• Reduces the long-term risk of liver failure and liver cancer once the virus is cleared
• Simple one-tablet-a-day regimen, typically for 12 weeks

Directions for Use

• Take exactly as prescribed – usually one tablet once daily for 12 weeks
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but take it at the same time every day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury – your doctor will screen and monitor for this
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort, certain HIV medicines and antacids, which can make this treatment fail
• Common side effects include headache, tiredness, nausea, diarrhoea, insomnia and anaemia
• Use with caution in severe kidney disease; liver function is monitored throughout treatment
• Avoid alcohol; it may cause dizziness or blurred vision, so do not drive until you know how it affects you

Storage

• Store below 30°C in a dry place
• Keep in the original bottle with the cap tightly closed; protect from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician, with the appropriate baseline tests.

The post Velpaclear Tablet appeared first on PMC Herbals.

Velpanat Tablet from Natco Pharma delivers Sofosbuvir 400 mg and Velpatasvir 100 mg in one daily tablet for chronic hepatitis C infection. Sofosbuvir halts the NS5B polymerase that copies the viral RNA; velpatasvir blocks NS5A, a protein essential for assembling and releasing new virus. Used together for 12 weeks they clear the virus from the blood in the large majority of patients, including those with compensated cirrhosis. Natco was among the first Indian firms licensed to produce these antivirals at accessible prices. Bottle of 28 tablets.

Key Features

• Sofosbuvir 400 mg + Velpatasvir 100 mg fixed-dose combination
• Pangenotypic cover across all six HCV genotypes
• Suitable in compensated cirrhosis as advised by your specialist
• One tablet daily – bottle of 28 tablets
• From Natco Pharma Ltd., a licensed generic producer

Composition

• Sofosbuvir – 400 mg (NS5B polymerase inhibitor)
• Velpatasvir – 100 mg (NS5A inhibitor)

Refer to the pack label and package insert for the complete list of excipients.

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and over
• Effective across all six HCV genotypes – no genotype testing needed before starting
• Clears the virus from the blood in over 95% of patients on a completed course
• Can be used in compensated cirrhosis, and with ribavirin in decompensated disease
• Reduces the long-term risk of liver failure and liver cancer once the virus is cleared
• Simple one-tablet-a-day regimen, typically for 12 weeks

Directions for Use

• Take exactly as prescribed – usually one tablet once daily for 12 weeks
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but take it at the same time every day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury – your doctor will screen and monitor for this
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort, certain HIV medicines and antacids, which can make this treatment fail
• Common side effects include headache, tiredness, nausea, diarrhoea, insomnia and anaemia
• Use with caution in severe kidney disease; liver function is monitored throughout treatment
• Avoid alcohol; it may cause dizziness or blurred vision, so do not drive until you know how it affects you

Storage

• Store below 30°C in a dry place
• Keep in the original bottle with the cap tightly closed; protect from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician, with the appropriate baseline tests.

The post Velpanat Tablet appeared first on PMC Herbals.

Resof Total Tablet from Dr Reddy’s Laboratories pairs Sofosbuvir 400 mg with Velpatasvir 100 mg in a single daily tablet for chronic hepatitis C. The two act at different points in the viral life cycle: sofosbuvir is a nucleotide analogue that shuts down the NS5B polymerase copying the viral genome, and velpatasvir is an NS5A inhibitor that stops new virus particles being assembled and released. Because the pairing covers every HCV genotype, treatment can begin without waiting for genotyping. Bottle of 28 tablets.

Key Features

• Sofosbuvir 400 mg + Velpatasvir 100 mg fixed-dose combination
• Covers all six HCV genotypes – no genotyping needed before starting
• Single tablet once daily, with or without food
• Bottle of 28 tablets – four weeks of therapy
• From Dr Reddy’s Laboratories Ltd.

Composition

• Sofosbuvir – 400 mg (NS5B polymerase inhibitor)
• Velpatasvir – 100 mg (NS5A inhibitor)

Refer to the pack label and package insert for the complete list of excipients.

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and over
• Effective across all six HCV genotypes – no genotype testing needed before starting
• Clears the virus from the blood in over 95% of patients on a completed course
• Can be used in compensated cirrhosis, and with ribavirin in decompensated disease
• Reduces the long-term risk of liver failure and liver cancer once the virus is cleared
• Simple one-tablet-a-day regimen, typically for 12 weeks

Directions for Use

• Take exactly as prescribed – usually one tablet once daily for 12 weeks
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but take it at the same time every day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury – your doctor will screen and monitor for this
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort, certain HIV medicines and antacids, which can make this treatment fail
• Common side effects include headache, tiredness, nausea, diarrhoea, insomnia and anaemia
• Use with caution in severe kidney disease; liver function is monitored throughout treatment
• Avoid alcohol; it may cause dizziness or blurred vision, so do not drive until you know how it affects you

Storage

• Store below 30°C in a dry place
• Keep in the original bottle with the cap tightly closed; protect from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician, with the appropriate baseline tests.

The post Resof Total Tablet appeared first on PMC Herbals.

Hepcvel Tablet from Cipla Ltd. combines Sofosbuvir 400 mg with Velpatasvir 100 mg – a pangenotypic direct-acting antiviral pairing that treats all six hepatitis C genotypes without needing genotype testing first. Sofosbuvir blocks the NS5B polymerase the virus uses to copy its genome, while Velpatasvir inhibits the NS5A protein it needs to assemble new virus particles. Attacking two separate steps at once is what makes cure rates above 95% achievable in a 12-week course, and it leaves the virus little room to develop resistance. Bottle of 28 tablets – four weeks of therapy.

Key Features

• Sofosbuvir 400 mg + Velpatasvir 100 mg fixed-dose combination
• Pangenotypic – effective across all six HCV genotypes
• One tablet daily, with or without food
• Bottle of 28 tablets – one month of a typical 12-week course
• From Cipla Ltd., a WHO-prequalified Indian manufacturer

Composition

• Sofosbuvir – 400 mg (NS5B polymerase inhibitor)
• Velpatasvir – 100 mg (NS5A inhibitor)

Uses & Benefits

• Treatment of chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and over
• Effective across all six HCV genotypes – no genotype testing needed before starting
• Clears the virus from the blood in over 95% of patients on a completed course
• Can be used in compensated cirrhosis, and with ribavirin in decompensated disease
• Reduces the long-term risk of liver failure and liver cancer once the virus is cleared
• Simple one-tablet-a-day regimen, typically for 12 weeks

Directions for Use

• Take exactly as prescribed – usually one tablet once daily for 12 weeks
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, but take it at the same time every day
• Complete the full course even when you feel well – stopping early risks relapse and resistance
• If you miss a dose, take it as soon as you remember unless the next is near; never double up

Precautions

• You must be tested for hepatitis B before starting. HBV can reactivate during HCV treatment and cause serious, sometimes fatal, liver injury – your doctor will screen and monitor for this
• Do not take with amiodarone – the combination can cause severe, potentially fatal slowing of the heart
• Tell your doctor about all other medicines, especially rifampicin, carbamazepine, phenytoin, St John’s Wort, certain HIV medicines and antacids, which can make this treatment fail
• Common side effects include headache, tiredness, nausea, diarrhoea, insomnia and anaemia
• Use with caution in severe kidney disease; liver function is monitored throughout treatment
• Avoid alcohol; it may cause dizziness or blurred vision, so do not drive until you know how it affects you

Storage

• Store below 30°C in a dry place
• Keep in the original bottle with the cap tightly closed; protect from light and moisture
• Keep out of reach of children

Disclaimer

Prescription medicine – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Hepatitis C therapy must be started and monitored by a qualified hepatologist or physician, with the appropriate baseline tests.

The post Hepcvel Tablet appeared first on PMC Herbals.